# Correction: Rubidium chloride targets Jnk/p38-mediated NF-κB activation to attenuate osteoclastogenesis and facilitate osteoblastogenesis

**Authors:** Zhengxiao Ouyang, Qianli Huang, Bin Liu, Hong Wu, Tang Liu, Yong Liu

PMC · DOI: 10.3389/fphar.2025.1678247 · Frontiers in Pharmacology · 2026-01-08

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}
- **Chemicals:** Rubidium chloride (MESH:C032710)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12826069/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12826069/full.md

---
Source: https://tomesphere.com/paper/PMC12826069